IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis

[1]  A. Rudensky,et al.  Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease , 2007, The Journal of experimental medicine.

[2]  David C. Gondek,et al.  Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.

[3]  G. Doria,et al.  Cutting Edge: IL-4-Induced Protection of CD4+CD25− Th Cells from CD4+CD25+ Regulatory T Cell-Mediated Suppression1 , 2006, The Journal of Immunology.

[4]  G. Comi,et al.  Motor evoked potentials in a mouse model of chronic multiple sclerosis , 2006, Muscle & nerve.

[5]  G. Comi,et al.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism , 2005, Nature.

[6]  M. Israel,et al.  Diffuse encephaloventriculitis and substantial leukoencephalopathy after intraventricular administration of recombinant adenovirus , 2005, Neurological research.

[7]  S. Sakaguchi.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[8]  S. Ibayashi,et al.  Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia , 2005, Gene Therapy.

[9]  S. Howng,et al.  Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia. , 2005, Brain research. Molecular brain research.

[10]  J. Bluestone,et al.  Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Wood,et al.  Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS , 2004, Gene Therapy.

[12]  L. Adorini,et al.  A Vitamin D Analog Down-Regulates Proinflammatory Chemokine Production by Pancreatic Islets Inhibiting T Cell Recruitment and Type 1 Diabetes Development1 , 2004, The Journal of Immunology.

[13]  E. Ongini,et al.  A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.

[14]  R. Ransohoff,et al.  Chemokine Upregulation Follows Cytokine Expression in Chronic Relapsing Experimental Autoimmune Encephalomyelitis , 2003, Scandinavian journal of immunology.

[15]  X. Breakefield,et al.  Viral vectors for gene delivery to the nervous system , 2003, Nature Reviews Neuroscience.

[16]  G. Tsujimoto,et al.  Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. , 2002, Blood.

[17]  W. Pardridge,et al.  Drug and Gene Delivery to the Brain The Vascular Route , 2002, Neuron.

[18]  L. Adorini,et al.  Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation , 2002, Journal of Neuroimmunology.

[19]  W. Pardridge,et al.  Drug and gene targeting to the brain with molecular trojan horses , 2002, Nature Reviews Drug Discovery.

[20]  A. Iellem,et al.  Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells , 2001, The Journal of experimental medicine.

[21]  G. Comi,et al.  The ependymal route to the CNS: an emerging gene-therapy approach for MS. , 2001, Trends in immunology.

[22]  M. Rovaris,et al.  Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. , 2001, Human gene therapy.

[23]  A. Consiglio,et al.  In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice , 2001, Nature Medicine.

[24]  A. Bout,et al.  Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity , 2000, Gene Therapy.

[25]  S. Kochanek,et al.  Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Cortese,et al.  Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Kochanek,et al.  Persistence in muscle of an adenoviral vector that lacks all viral genes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Adorini,et al.  Exploiting the potential of regulatory T cells in the control of type 1 diabetes , 2005 .

[29]  M. Wauben,et al.  Regulatory T cells in inflammation , 2005 .

[30]  G. Comi,et al.  Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice , 2001, Gene Therapy.